Gregory Martin, MD
Surgery · Valdosta, GANPI 1194782771
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (55.7%), education and food and beverage — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 97.5% of it on its own, with 7 other manufacturers making up the rest. Among surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $906.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$34K
- Boston Scientific$304
- Bard Peripheral Vascular, Inc.$267
- Koya Medical, Inc.$100
- Organogenesis Inc.$89
- Galderma Laboratories, L.p.$44
- plus $47 from 2 others
What the payments were for
- Food & beverage$8512%
- Education$14,40042%
- Other$19,20056%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 7 | $33,600 |
| Boston Scientific | 14 | $304 |
| Bard Peripheral Vascular, Inc. | 6 | $267 |
| Koya Medical, Inc. | 1 | $100 |
| Organogenesis Inc. | 5 | $89 |
| Galderma Laboratories, L.p. | 3 | $44 |
| Medtronic | 1 | $30 |
| Cashflow Solutions, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$24,000
- EVLT$9,600
- Koya Medical$200
- Dayspring$200
How this compares
$34,451 in reported general payments places this provider in the 95th percentile of 855 surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $81 |
| Diazepam | 18 | $13 |
Paid to pharmacies, not to this prescriber.
Other surgery in Valdosta
- Chad CopperGainesville$999K
- Zachary KlaassenAugusta$763K
- Stephen OdomAustell$599K
- Fritz Jean-PierreMarietta$464K
- Kendra GrubbAtlanta$374K
- Harry LightfootSmyrna$241K
- Oliver WhippleSavannah$222K
- Nelson RoyallGainesville$220K
- Ankit PatelAtlanta$217K
- Kevin NguyenAtlanta$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.